Tech Company Financing Transactions
Tessa Therapeutics Funding Round
Tessa Therapeutics closed a $126 million Series A funding round on 6/9/2022. Investors included Polaris Partners, Edbi and Heliconia Capital Management.
Transaction Overview
Company Name
Announced On
6/9/2022
Transaction Type
Venture Equity
Amount
$126,000,000
Round
Series A
Investors
Polaris Partners (Lead Investor) (Amy Schulman)
Proceeds Purpose
This financing will be instrumental to helping us achieve several key near-term milestones, including the initiation of a pivotal clinical trial of our TT11 program and advancement of our TT11X program.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
8 Temasek Boulevard, #24-02 Suntec Tower 3
Singapore, 038988
Singapore
Singapore, 038988
Singapore
Phone
Website
Email Address
Overview
Tessa Therapeutics is a clinical-stage biotechnology company developing a portfolio of novel next-generation cell therapies for cancer. Tessa is leading the way in CD30 targeting using cell therapy. CD30 is a well validated lymphoma target with homogenous expression in Classical Hodgkin Lymphoma and multiple subsets of non-Hodgkin Lymphomas. Tessa's approach to target CD30-positive cancers using CAR-T (Chimeric Antigen Receptor) cells has demonstrated excellent safety and efficacy in early clinical trials. Having received the RMAT and PRIME designation, Tessa is now advancing the therapy to a pivotal trial.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Göran Ando
Chief Executive Officer
John Ng
Chief Financial Officer
Wilson Cheung
Chief Medical Officer
Ivan Horak
Browse more venture capital transactions:
Prev: 6/9/2022: SuperTeam Games venture capital transaction
Next: 6/9/2022: Backbase venture capital transaction
Share this article
News on VC Transactions
We do our best to report on every notable VC transaction. VC transactions reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs